Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, Korenfeld D, Mathyer ME, Kim H, Huang LH, Duncan D, Bregman H, Keskin A, Santeford A, Apte RS, Sehgal R, Johnson B, Amarasinghe GK, Soares MP, Satoh T, Akira S, Hai T, de Guzman SC, Auclair K, Roddy TP, Biller SA, Jovanovic M, Klechevsky E, Stewart KM, Randolph GJ, Artyomov MN (2018) Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature 556(7702):501–504. https://doi.org/10.1038/s41586-018-0052-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bazan L, Bendas ER, El Gazayerly ON, Badawy SS (2016) Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro-in-vivo evaluation. Drug Deliv 23(9):3339–3349. https://doi.org/10.1080/10717544.2016.1178824

Article  CAS  PubMed  Google Scholar 

Bel S, Elkis Y, Lerer-Goldstein T, Nyska A, Shpungin S, Nir U (2012) Loss of TMF/ARA160 protein renders colonic mucus refractory to bacterial colonization and diminishes intestinal susceptibility to acute colitis. J Biol Chem 287(30):25631–25639. https://doi.org/10.1074/jbc.M112.364786

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burri E, Maillard MH, Schoepfer AM, Seibold F, Van Assche G, Riviere P, Laharie D, Manz M, Swiss Ibdnetaowgot SSoG (2020) Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update. Digestion 101(Suppl 1):2–15. https://doi.org/10.1159/000504092

Article  CAS  PubMed  Google Scholar 

Cai C, Ma H, Peng J, Shen X, Zhen X, Yu C, Zhang P, Ji F, Wang J (2023) USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat Commun 14(1):3648. https://doi.org/10.1038/s41467-023-39412-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calder PC (2020) Eicosanoids. Essays Biochem 64(3):423–441. https://doi.org/10.1042/EBC20190083

Article  CAS  PubMed  Google Scholar 

Campbell EL, Colgan SP (2019) Control and dysregulation of redox signalling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 16(2):106–120. https://doi.org/10.1038/s41575-018-0079-5

Article  PubMed  PubMed Central  Google Scholar 

Cinelli MA, Do HT, Miley GP, Silverman RB (2020) Inducible nitric oxide synthase: regulation, structure, and inhibition. Med Res Rev 40(1):158–189. https://doi.org/10.1002/med.21599

Article  CAS  PubMed  Google Scholar 

Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69(2):238–249

CAS  PubMed  Google Scholar 

Cordes T, Lucas A, Divakaruni AS, Murphy AN, Cabrales P, Metallo CM (2020) Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab 32:122–135. https://doi.org/10.1016/j.molmet.2019.11.019

Article  CAS  PubMed  Google Scholar 

Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140(6):1785–1794. https://doi.org/10.1053/j.gastro.2011.01.055

Article  PubMed  Google Scholar 

Dinkova-Kostova AT, Talalay P (2010) NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 501(1):116–123. https://doi.org/10.1016/j.abb.2010.03.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du J, Zhang J, Wang L, Wang X, Zhao Y, Lu J, Fan T, Niu M, Zhang J, Cheng F, Li J, Zhu Q, Zhang D, Pei H, Li G, Liang X, Huang H, Cao X, Liu X, Shao W, Sheng J (2023) Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis. Nat Commun 14(1):3675. https://doi.org/10.1038/s41467-023-39173-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Hady SM, Aboughaly MHH, El-Ashmoony MM, Helmy HS, El-Gazayerly ON (2020) Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. Int J Pharm 25(576):118982. https://doi.org/10.1016/j.ijpharm.2019.118982

Article  CAS  Google Scholar 

Fraser AG, Orchard TR, Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50(4):485–489. https://doi.org/10.1136/gut.50.4.485

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin Biroulet L, Sandborn WJ (2018) Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 16(3):343–356. https://doi.org/10.1016/j.cgh.2017.06.016

Article  PubMed  Google Scholar 

Gupta RA, Motiwala MN, Dumore NG, Danao KR, Ganjare AB (2015) Effect of piperine on inhibition of FFA induced TLR4 mediated inflammation and amelioration of acetic acid induced ulcerative colitis in mice. J Ethnopharmacol 164:239–246. https://doi.org/10.1016/j.jep.2015.01.039

Article  CAS  PubMed  Google Scholar 

Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C, Ruzek MC, Slivka PF, McGettrick AF, Banahan K, Hughes MM, Irvine AD, Fischer R, O’Neill LAJ (2020) The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metab 32(3):468–478. https://doi.org/10.1016/j.cmet.2020.07.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarmakiewicz-Czaja S, Ferenc K, Filip R (2023) Antioxidants as Protection against Reactive Oxidative Stress in Inflammatory Bowel Disease. Metabolites 13(4):573. https://doi.org/10.3390/metabo13040573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jena G, Trivedi PP, Sandala B (2012) Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radic Res 46(11):1339–1345. https://doi.org/10.3109/10715762.2012.717692

Article  CAS  PubMed  Google Scholar 

Kim HW, Yu AR, Lee JW, Yoon HS, Lee BS, Park HW, Lee SK, Lee YI, Whang J, Kim JS (2022) Aconitate Decarboxylase 1 Deficiency Exacerbates Mouse Colitis Induced by Dextran Sodium Sulfate. Int J Mol Sci 23(8):4392. https://doi.org/10.3390/ijms23084392

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T (2020) Ulcerative Colitis Nat Rev Dis Primers 6(1):74. https://doi.org/10.1038/s41572-020-0205-x

Article  PubMed  Google Scholar 

Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, Cervantes-Barragan L, Ma X, Huang SC, Griss T, Weinheimer CJ, Khader S, Randolph GJ, Pearce EJ, Jones RG, Diwan A, Diamond MS, Artyomov MN (2016) Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab 24(1):158–166. https://doi.org/10.1016/j.cmet.2016.06.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee CG, Jenkins NA, Gilbert DJ, Copeland NG, O’Brien WE (1995) Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41(5):263–270. https://doi.org/10.1007/BF00172150

Article  CAS  PubMed  Google Scholar 

Lee Y, Kim W, Hong S, Park H, Yum S, Yoon JH et al (2014) Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages. Eur J Pharmacol 726:49–56. https://doi.org/10.1016/j.ejphar.2014.01.011

Article  CAS  PubMed  Google Scholar 

Li Y, Chen X, Zhang H, Xiao J, Yang C, Chen W, Wei Z, Chen X, Liu J (2020) 4-Octyl Itaconate Alleviates Lipopolysaccharide-induced acute lung injury in mice by inhibiting oxidative stress and inflammation. Drug Des Devel Ther 14:5547–5558. https://doi.org/10.2147/DDDT.S280922

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY (2019) 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat Commun 10(1):5091. https://doi.org/10.1038/s41467-019-13078-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luis AS, Hansson GC (2023) Intestinal mucus and their glycans: a habitat for thriving microbiota. Cell Host Microbe 31(7):1087–1100. https://doi.org/10.1016/j.chom.2023.05.026

Article  CAS  PubMed  Google Scholar 

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagorowicz E, Raine T, Harbord M, Rieder F, Cs E, Colitis O (2017) Third european evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 11(6):649–670. https://doi.org/10.1093/ecco-jcc/jjx008

Article  PubMed  Google Scholar 

Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, Runtsch MC, King MS, McGouran JF, Fischer R, Kessler BM, McGettrick AF, Hughes MM, Carroll RG, Booty LM, Knatko EV, Meakin PJ, Ashford MLJ, Modis LK, Brunori G, Sevin DC, Fallon PG, Caldwell ST, Kunji ERS, Chouchani ET, Frezza C, Dinkova-Kostova AT, Hartley RC, Murphy MP, O’Neill LA (2018) Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556(7699):113–117. https://doi.org/10.1038/nature25986

Article  CAS  PubMed  PubMed Central